Association of angiotensinogen gene polymorphisms and angiogenic factors with preeclampsia in chinese women

Gynecologic and Obstetric Investigation

Volumn 76, Issue 1, 2013, Pages 64-68

  Song, Chengwen ^a   Xie, Shouzhen ^a   Wang, Jing ^a   Lian, Junhong ^a   Diao, Bo ^a   Tang, Ying ^a  

^a WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

Author keywords

Angiotensinogen gene M235T polymorphism; Placental growth factor; Preeclampsia; Soluble fms like tyrosine kinase 1; Vascular endothelial growth factor

Indexed keywords

ANGIOGENIC FACTOR; ANGIOTENSINOGEN; PLACENTAL GROWTH FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; GESTATIONAL AGE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SERUM; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ALLELE; BLOOD LEVEL;

ADULT; ALLELES; ANGIOTENSINOGEN; CHI-SQUARE DISTRIBUTION; CHINA; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84882319589     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000352070     Document Type: Article

References (23)

1. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K, Lalouel JM: Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994; 93: 1285-1287.
2. Kobashi G, Shido K, Hata A, Yamada H, Kato EH, Kanamori M, et al: Multivariate analysis of genetic and acquired factors: T235 variant of the angiotensinogen gene is a potent independent risk factor for preeclampsia. Semin Thromb Hemost 2001; 27: 143-147.
3. Guo G, Wilton AN, Fu Y, Qiu H, Brennecke SP, Cooper DW: Angiotensinogen gene variation in a population case-control study of preeclampsia in Australians and Chinese. Electrophoresis 1997; 18: 1646-1649.
4. Morgan L, Crawshaw S, Baker PN, Broughton Pipkin F, Kalsheker N: Maternal and fetal angiotensinogen gene allele sharing in pre-eclampsia. Br J Obstet Gynaecol 1999; 106: 244-251.
5. Bashford MT, Hefler LA, Vertrees TW, Roa BB, Gregg AR: Angiotensinogen and endothelial nitric oxide synthase gene polymorphisms among Hispanic patients with preeclampsia. Am J Obstet Gynecol 2001; 184: 1345-1350.
6. Pfab T, Stirnberg B, Sohn A, Krause K, Slowinski T, Godes M, Guthmann F, Wauer R, Halle H, Hocher B: Impact of maternal angiotensinogen M235T polymorphism and angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure, protein excretion and fetal outcome in pregnancy. J Hypertens 2007; 25: 1255-1261.
7. Suzuki H, Ohkuchi A, Matsubara S, Takei Y, Murakami M, Shibuya M, Suzuki M, Sato Y: Effect of recombinant placental growth factor2 on hypertension induced by full-length mouse soluble fms-like tyrosine kinase 1 adenoviral vector in pregnant mice. Hypertension 2009; 54: 1129-1135.
8. Ahmed A, Dunk C, Ahmad S, Khaliq A: Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PlGF) and soluble Flt-1 by oxygen-a review. Placenta 2000; 218(suppl A):S16-S24.
9. Amburgey OA, Chapman AC, May V, Bernstein IM, Cipolla MJ: Plasma from preeclamptic women increases blood-brain barrier permeability: role of vascular endothelial growth factor signaling. Hypertension 2010; 56: 1003-1008.
10. Murphy SR, LaMarca BB, Cockrell K, Granger JP: Role of endothelin in mediating soluble fms-like tyrosine kinase-1 (sFlt-1)-induced hypertension in pregnant rats. Hypertension 2010; 55: 394-398.
11. Gilbert JS, Ryan MJ, LaMarca BB, Sedeek M, Murphy SR, Granger JP: Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol 2008; 294:H541-H550.
12. Agarwal I, Karumanchi SA: Preeclampsia and the anti-angiogenic state. Pregnancy Hypertens 2011; 1: 17-21.
13. Morrison AC, Srinivas SK, Elovitz MA, Puschett JB: Genetic variation in solute carrier genes is associated with preeclampsia. Am J Obstet Gynecol 2010; 203: 491. e1-e13.
14. Kim YJ, Park MH, Park HS, Lee KS, Ha EH, Pang MG: Associations of polymorphisms of the angiotensinogen M235 polymorphism and angiotensin-converting-enzyme intron 16 insertion/deletion polymorphism with preeclampsia in Korean women. Eur J Obstet Gynecol Reprod Biol 2004; 116: 48-53.
15. Choi H, Kang JY, Yoon HS, Han SS, Whang CS, Moon IG, Shin HH, Park JB: Association of angiotensin-converting enzyme and angiotensinogen gene polymorphisms with preeclampsia. J Korean Med Sci 2004; 19: 253-257.
16. Ishimaru T, Ishida J, Nakamura S, Hashimoto M, Matsukura T, Nakamura A, Kunita S, Sugiyama F, Yagami K, Fukamizu A: Shortterm suppression of the renin-angiotensin system in mice associated with hypertension during pregnancy. Mol Med Report 2012; 6: 28-32.
17. Irani RA, Xia Y: Renin angiotensin signaling in normal pregnancy and preeclampsia. Semin Nephrol 2011; 31: 47-58.
18. Powers RW, Jeyabalan A, Clifton RG, Van Dorsten P, Hauth JC, Klebanoff MA, Lindheimer MD, Sibai B, Landon M, Miodovnik M, Eunice Kennedy Shriver National Institute of Child Health Human Development Maternal-Fetal Medicine Units Network: Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies. PLoS One 2010; 5:e13263.
19. Uddin MN, Agunanne E, Horvat D, Puschett JB: Alterations in the renin-angiotensin system in a rat model of human preeclampsia. Am J Nephrol 2010; 31: 171-177.
20. Robinson CJ, Johnson DD, Chang EY, Armstrong DM, Wang W: Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia. Am J Obstet Gynecol 2006; 195: 255-259.
21. Bereketolu C, Kasap M, Pazarba A: Studies on angiotensin-converting enzyme insertion/ deletion polymorphism and genotype distributions in Turkish preeclampsia patients. J Pregnancy 2012; 2012: 108206.
22. Sibiude J, Guibourdenche J, Dionne MD, Le Ray C, Anselem O, Serreau R, Goffinet F, Tsatsaris V: Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction. PLoS One 2012; 7: e50208.
23. Williams PJ, Morgan L: The role of genetics in pre-eclampsia and potential pharmacogenomic interventions. Pharmgenomics Pers Med 2012; 5: 37-51.